Muscle-Invasive Bladder Carcinoma Clinical Trials

50 clinical trials for Muscle-Invasive Bladder Carcinoma across international registries, including 23 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial — RECRUITING · PHASE1
• Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology — RECRUITING · PHASE2
• Partial Cystectomy & Extended Pelvic Lymph Node Dissection With SOC Perioperative Systemic Therapy — RECRUITING · PHASE2
• Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection — RECRUITING
• Adaptive RADiation Therapy With Concurrent Sacituzumab Govitecan (SG) for Muscle Invasive Bladder Cancer — RECRUITING · PHASE1
• Personalized Cancer Vaccine (PCV) Strategy in Patients With Solid Tumors and Molecular Residual Disease — RECRUITING · PHASE1
• Enfortumab Vedotin and Pembrolizumab Combined With Radiotherapy in Muscle Invasive Bladder Cancer — RECRUITING · PHASE1
• Clinical Trial to Evaluate Post-Operative Outcomes of Ureteral Stent vs Ureteral Stent Free Radical Cystectomy — RECRUITING · NA
• Supporting Sexual Health in Bladder Cancer Patients: A Sequential Mixed-Methods Intervention Study — RECRUITING · NA
• Futibatinib in Combination With Durvalumab Prior to Cystectomy for the Treatment of Muscle-Invasive Bladder Cancer Patients Who Are Ineligible for Cisplatin-based Therapy — RECRUITING · PHASE2
• Interest of Late Images for the Assessment of Extensions in 18FGD PET-CT of Muscle-Invasive Bladder Cancers — RECRUITING · NA
• Prophylactic Antibiotics in Cystectomy With Diversion — RECRUITING · PHASE1
• Gemcitabine/Cisplatin Plus Cemiplimab With or Without Fianlimab in Localized Muscle-invasive Bladder Cancer (NeoSTOP-IT) — RECRUITING · PHASE2
• NEO-BLAST: Neoadjuvant Therapy for Bladder Cancer Followed by Active Surveillance vs Treatment — RECRUITING · PHASE2
• Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma — RECRUITING · PHASE2
• Modular Trial of sEphB4-HSA in EphrinB2-High Solid Tumors — RECRUITING · PHASE2
• Evaluating the Impact of 18F-FDG-PET-CT on Risk Stratification and Treatment Adaptation for Patients with Muscle Invasive Bladder Cancer — RECRUITING · PHASE2
• Pre-Habilitation with Mindfulness and Exercise for Patients Undergoing Radical Cystectomy (PRIMER Trial) — RECRUITING · NA
• RC48 Combined with Toripalimab As Neoadjuvant Therapy for Cisplatin Ineligible MIBC Patients — RECRUITING · PHASE1
• Cisplatin, Nab-paclitaxel, Nivolumab With Radiotherapy After Resection of Non-Metastatic Muscle Invasive Bladder Cancer — RECRUITING · PHASE2
• The Nephroprotective Effect of Metformin With Cisplatin in Bladder Cancer — RECRUITING · PHASE4
• Study on the Quality of Life and Pathological State in Patients Who Underwent Radical Cystectomy — RECRUITING
• Robotic Radical Cystectomy Outcomes — RECRUITING
• Chemoradiotherapy With or Without Atezolizumab in Treating Patients With Localized Muscle Invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE3
• Sacituzumab Govitecan Before Radical Cystectomy for the Treatment of Non-Urothelial Muscle Invasive Bladder Cancer — TERMINATED · PHASE2
• Immune-Stromal Landscape in Muscle-Invasive Bladder Cancer — NOT_YET_RECRUITING
• Pembrolizumab in Muscle-invasive Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Conventionally Fractionated Adaptive Radiation Therapy of Bladder Cancer an Individualized Approach — ACTIVE_NOT_RECRUITING · NA
• Study of CG0070 Combined With Nivolumab in Cisplatin Ineligible Patients With MIBC — COMPLETED · PHASE1
• Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation — ACTIVE_NOT_RECRUITING · PHASE2
• ctDNA in Subjects With Muscle-invasive Bladder Cancer Treated With Trimodality Therapy — COMPLETED
• Testing Anti-Cancer Drugs Erdafitinib With or Without Atezolizumab in Patients With Localized Bladder Cancer Not Able to Receive Cisplatin Chemotherapy, NERA Trial — WITHDRAWN · PHASE2
• Pembrolizumab and Combination Chemotherapy Before Surgery for the Treatment of Muscle-Invasive Bladder Cancer — COMPLETED · PHASE2
• A Study of Risk Enabled Therapy After Neoadjuvant Immunochemotherapy for Bladder Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study — COMPLETED
• Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt — ACTIVE_NOT_RECRUITING · PHASE3
• Bladder Preservation With Sacituzumab Govitecan + Zimberelimab for Muscle-Invasive Bladder Cancer — NOT_YET_RECRUITING · PHASE2
• Predicting Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder Cancer — NOT_YET_RECRUITING
• A Study of RC48-ADC Combined With JS001 For Perioperative Treatment of Muscle-Invasive Bladder Cancer — OTHER · PHASE2
• A Study of RC48-ADC Combined With AK104 For Perioperative Treatment of Muscle-Invasive Bladder Cancer — OTHER · PHASE2
• Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection — OTHER
• Clinical Performance Evaluation of the C2i-Test — TERMINATED
• Addressing Barriers to Palliative Care Use in Bladder Cancer — COMPLETED
• FL- 101 Study in Non-Metastatic MIBC — WITHDRAWN · PHASE1
• An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo) — OTHER · PHASE2
• Clinical Utility of VI-RADS in Diagnosis of MIBC — OTHER
• Effect of Urinary Indwelling Time on Early Continence After Robot-assisted Radical Cystectomy With Orthotopic Ileal Neobladder. — OTHER
• Chemotherapy Combined With Tislelizumab as Bladder Sparing Option for Patients With Muscle Invasive Bladder Cancer — OTHER · PHASE2
• a Genome-based Platform to Predict Patients That Can Achieve Bladder Preservation in Muscle Invasive Bladder Cancer Patients — OTHER
• Chemoradiation for Bladder Preservation After Complete Response to Neoadjuvant Chemotherapy — TERMINATED · NA

Refine this search